1. Capecitabine plus gemcitabine in thymic epithelial tumors: final analysis of a Phase II trial. (November 2014) Authors: Palmieri, Giovannella; Buonerba, Carlo; Ottaviano, Margaret; Federico, Piera; Calabrese, Filomena; Von Arx, Claudia; De Maio, Ana Paula; Marino, Mirella; Lalle, Maurizio; Montella, Liliana; Merola, Carmela; Milella, Michele; Bergaglio, Marina; Di Lorenzo, Giuseppe; Damiano, Vincenzo Journal: Future oncology Issue: Volume 10:Number 14(2014) Page Start: 2141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Human epidermal growth factor receptor 2 dual blockade with trastuzumab and pertuzumab in real life: Italian clinical practice versus the CLEOPATRA trial results. (April 2018) Authors: De Placido, Sabino; Giuliano, Mario; Schettini, Francesco; Von Arx, Claudia; Buono, Giuseppe; Riccardi, Ferdinando; Cianniello, Daniela; Caputo, Roberta; Puglisi, Fabio; Bonotto, Marta; Fabi, Alessandra; Bilancia, Domenico; Ciccarese, Mariangela; Lorusso, Vito; Michelotti, Andrea; Bruzzese, Dario... Journal: Breast Issue: Volume 38(2018) Page Start: 86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. MO234LIFE THREATENING MALIGNANT HYPERCALCEMIA IN BREAST CANCER: CAN THE NEPHROLOGIST CHANGE THE PATIENT DESTINY?. (29th May 2021) Authors: Pensabene, Matilde; Von Arx, Claudia; Giuliana, Sofia; Calabrese, Filomena; Capodanno, Paola; Piscopo, Anna Maria; Cavalcanti, Ernesta; Cuomo, Arturo; Capasso, Giovambattista; De Laurentiis, Michelino; Simeoni, Mariadelina Journal: Nephrology dialysis transplantation Issue: Volume 36(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗